Sökresultat - Marı́a Buti

Förfina resultatet
  1. 1
    Management of direct antiviral agent failures

    Management of direct antiviral agent failures av Marı́a Buti, Rafael Esteban

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Natural History and Management of Hepatitis C: Does Sex Play a Role?

    Natural History and Management of Hepatitis C: Does Sex Play a Role? av Rachel Baden, Jürgen K. Rockstroh, Marı́a Buti

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Long‐term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B

    Long‐term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B av Marı́a Buti, Mar Riveiro‐Barciela, Rafael Esteban

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  4. 4
    Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B

    Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B av Luisa Roade, Mar Riveiro‐Barciela, Rafael Esteban, Marı́a Buti

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  5. 5
    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients av Markus Cornberg, Marı́a Buti, Christiane S. Eberhardt, Paolo Grossi, Daniel Shouval

    Publicerad 2021
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  6. 6
    Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

    Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoint... av Marc G. Ghany, Marı́a Buti, Pietro Lampertico, Hannah M. Lee

    Publicerad 2023
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis

    Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis av Sonia Pina-Pedrero, Marı́a Buti, R Jardí, Pilar Clemente-Casares, Joan Jofre, Rosina Gironés

    Publicerad 2001
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations

    Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations av Francisco Rodríguez‐Frías, Marı́a Buti, Rosendo Jardí, Montserrat Cotrina, L Viladomiu, Rafael Esteban, Jaime Guardia

    Publicerad 1995
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)

    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020) av Manuel Rodríguez, Marı́a Buti, Rafael Esteban, Sabela Lens, M. Prieto, Emilio Suárez, Javier García‐Samaniego

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

    Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative inte... av Rosendo Jardí, F. Rodrı́guez, Marı́a Buti, X. Costa, Montserrat Cotrina, R. Galimany, Rafael Esteban, Jaime Guardia

    Publicerad 2001
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

    Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin av Marı́a Buti, J.F. Sánchez-Ávila, Yoav Lurie, Carlos Stalgis, Auristela Valdés, M. Martell, Rafael Esteban

    Publicerad 2002
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey

    Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey av Loreta A. Kondili, Marı́a Buti, Mar Riveiro‐Barciela, Mojca Matičič, Francesco Negro, Thomas Berg, Antonio Craxı̀

    Publicerad 2022
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Hepatitis E Virus Epidemiology in Industrialized Countries

    Hepatitis E Virus Epidemiology in Industrialized Countries av Pilar Clemente-Casares, Sonia Pina-Pedrero, Marı́a Buti, R Jardí, Marga Martı́n, Sílvia Bofill-Mas, Rosina Gironés

    Publicerad 2003
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study

    Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study av A. Singer, K. Rajender Reddy, Laura Telep, Anu Osinusi, Diana M. Brainard, Marı́a Buti, Anand P. Chokkalingam

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?

    Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies? av Mar Riveiro‐Barciela, Eva Muñoz‐Couselo, Jesús Fernández‐Sojo, Nely Díaz‐Mejía, Rafael Parra-López, Marı́a Buti

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  16. 16
    Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study

    Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study av Marı́a Buti, María Homs, Francisco Rodríguez‐Frías, G. Funalleras, Rosendo Jardí, Sílvia Sauleda, David Tabernero, M. Schaper, Rafael Esteban

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Adherence to Lamivudine After an Early Withdrawal of Hepatitis B Immune Globulin Plays an Important Role in the Long-Term Prevention of Hepatitis B Virus Recurrence

    Adherence to Lamivudine After an Early Withdrawal of Hepatitis B Immune Globulin Plays an Important Role in the Long-Term Prevention of Hepatitis B Virus Recurrence av Marı́a Buti, Antoni Mas, M. Prieto, Fernando Casafont, Antonio González, Manuel Miras, J.I. Herrero, Rosendo Jardí, Rafael Esteban

    Publicerad 2007
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D

    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D av Marı́a Buti, José Luís Calleja, Miguel Ángel Rodríguez, Raquel Domínguez‐Hernández, Helena Cantero, Nataly Espinoza-Cámac, Miguel Á. Casado

    Publicerad 2025
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B …

    Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with he... av Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Jenny Heathcote, Marı́a Buti, Robert Goldin, Sasha Hawley, Judy Barber, Lynn D. Condreay, Fraser Gray

    Publicerad 1999
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Community-Based Seroepidemiological Survey of Hepatitis E Virus Infection in Catalonia, Spain

    Community-Based Seroepidemiological Survey of Hepatitis E Virus Infection in Catalonia, Spain av Marı́a Buti, Ángela Domı́nguez, Pere Plans, Rossend Jardí, M. Schaper, Jordi Espuñes, Neus Cardeñosa, Francisco Rodríguez‐Frías, Rafael Esteban, Antoni Plasència, L. Salleras

    Publicerad 2006
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: